Make your own free website on

Vector Design for DNA Vaccine - elegansNet-Selected Submissions & Publications

  Conditionally replicating viral vectors and their use
United States Patent 6,207,426      Dropulic ,   et al. March 27, 2001
  The Design and Development of Recombinant Vector-Based Vaccines to Elicit High-Intensity Immune Stimulation (2000)Jeffrey Schlom, Ph.D. Chief, Laboratory of Tumor Immunology and Biology National Cancer Institute
  CONSTRUCTION OF A RECOMBINANT LENTIVIRAL VECTOR (1997) Pat Metharom, BSc(Hons), Sir Albert Sakzewski Virus Research Centre, Royal Children's Hospital, Herston, Queensland, AUSTRALIA
  Genetic Immunization Using Recombinant Alphavirus Vector of HPV Proteins Could be Therapeutic, Prophylactic (2000) Daemen et. al.. Gene Therapy, 7(21):1859-1866. OBGYN.Net
  A Novel Dual Vector Approach to Enhance Recombinant AAV-mediated Gene Expression through Intermolecular Cis-activation (2000) Dongsheng Duan, Yongping Yue, Ziying Yan, John F. Engelhardt, Dep. of Anatomy and Cell Biology; Center for Gene Therapy; Dep. of Internal Medicine, College of Medicine, University of Iowa
  HIV Vaccines: Combination and Prime-Boost Strategies (2000) Matt Meldorf, MD, and Lawrence Corey, MD

Created 3/27/01; Updated: 09/10/2002 ; Question & Comments

Webcasted from the following sites:






Created: 1/20/00

Hit Counter